Prolapse surgery goes Same-Day: small study tests feasibility
NCT ID NCT02585544
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked at whether surgery for vaginal prolapse can be safely done as a day procedure, allowing women to go home the same day. Thirty-eight women with advanced prolapse were treated at three hospitals in Lyon, France. The goal was to see how many could actually be managed as day surgery and to track satisfaction, complications, and long-term results.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- day-care surgery
- What this could lead to
- If successful, this could show that prolapse surgery can be done as a day procedure, reducing hospital stays and improving patient comfort.
- What could go wrong
- This is a small, early feasibility study with only 38 participants, so results may not apply to all patients. Day surgery may fail or have higher complication rates in some cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
38 people
The number who actually took part.
- Started
-
Oct 2015
- Finished
-
Sep 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Stage III or IV anterior genital prolapse (cystocele) on the Pelvic Organ Prolapse Quantification (POP-Q) classification and/or vaginal floor prolapse * Vaginal approach with prosthetic reinforcement planned * Patient eligible for day-surgery * Patient consenting to participate * Informed and signed consent Exclusion Criteria: * Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, progressive disease, etc. * Patient with ≥1 ineligibility criterion for day-surgery * Impaired lower-limb range of motion preventing positioning for surgery * Pregnancy, ongoing or planned during the study period * Progressive or latent infection or signs of tissue necrosis on clinical examination * Non-controlled diabetes (glycated hemoglobin \>8%) * Treatment impacting immune response (immunomodulators), ongoing or within previous month * History of pelvic region radiation therapy, at any time * History of pelvic cancer * Non-controlled progressive spinal pathology * Known hypersensitivity to one of the implant components (polypropylene) * Inability to understand information provided * Not covered by a national health insurance scheme, prisoner or under administrative supervision.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Genital prolapse are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Femme Mère Enfant
Bron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.